Related references
Note: Only part of the references are listed.CCAAT-enhancer-binding protein-beta expression in vivo is associated with muscle strength
Lorna W. Harries et al.
AGING CELL (2012)
A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells
Fan Qu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2012)
The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome
Stefano Angioni et al.
GYNECOLOGICAL ENDOCRINOLOGY (2011)
The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies
Ilana J. Halperin et al.
HUMAN REPRODUCTION (2011)
Contemporary genetic technologies and female reproduction
HUMAN REPRODUCTION UPDATE (2011)
Effects of Exercise on Insulin Resistance and Body Composition in Overweight and Obese Women with and without Polycystic Ovary Syndrome
Samantha K. Hutchison et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
Esra Tasali et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The BioGRID Interaction Database: 2011 update
Chris Stark et al.
NUCLEIC ACIDS RESEARCH (2011)
Epigenetic Mechanism Underlying the Development of Polycystic Ovary Syndrome (PCOS)-Like Phenotypes in Prenatally Androgenized Rhesus Monkeys
Ning Xu et al.
PLOS ONE (2011)
Estrogen receptor beta gene+1730 G/A polymorphism in women with polycystic ovary syndrome
Jin Ju Kim et al.
FERTILITY AND STERILITY (2010)
The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome
Susanne Cupisti et al.
FERTILITY AND STERILITY (2010)
Pathogen recognition in the innate immune response
Himanshu Kumar et al.
BIOCHEMICAL JOURNAL (2009)
Regulation of estrogen receptor beta activity and implications in health and disease
Elin Swedenborg et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Effect of metformin, orlistat and pioglitazone treatment on mean insulin resistance and its biological variability in polycystic ovary syndrome
L. W. Cho et al.
CLINICAL ENDOCRINOLOGY (2009)
Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome
Flavia Tosi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome
Luciano G. Nardo et al.
HUMAN REPRODUCTION (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Genome-wide high throughput analysis of DNA methylation in eukaryotes
Kyle R. Pomraning et al.
METHODS (2009)
Human Protein Reference Database-2009 update
T. S. Keshava Prasad et al.
NUCLEIC ACIDS RESEARCH (2009)
Comprehensive high-throughput arrays for relative methylation (CHARM)
Rafael A. Irizarry et al.
GENOME RESEARCH (2008)
Epigenetic abnormality: A possible mechanism underlying the fetal origin of polycystic ovary syndrome
Zhongxiang Li et al.
MEDICAL HYPOTHESES (2008)
The Cebpd (C/EBPδ) Gene Is Induced by Luteinizing Hormones in Ovarian Theca and Interstitial Cells But Is Not Essential for Mouse Ovary Function
A-Mei Huang et al.
PLOS ONE (2007)
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
S. Horvath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
Ricardo Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The role of genes and environment in the etiology of PCOS
Evanthia Diamanti-Kandarakis et al.
ENDOCRINE (2006)
Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome
T. E. Hickey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Key cancer cell signal transduction pathways as therapeutic targets
RB Bianco et al.
EUROPEAN JOURNAL OF CANCER (2006)
Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays
LP Ly et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women:: results of a randomized study
E Vanky et al.
HUMAN REPRODUCTION (2004)
The prevalence and features of the polycystic ovary syndrome in an unselected population
R Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Insulin sensitizers for polycystic ovary syndrome
JP Baillargeon et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Reduced IRS-2 and GLUT4 expression in PPARγ2-induced adipocytes derived from C/EBPβ and C/EBPδ-deficient mouse embryonic fibroblasts
H Yamamoto et al.
JOURNAL OF CELL SCIENCE (2002)
Molecular progress in infertility: polycystic ovary syndrome
RS Legro et al.
FERTILITY AND STERILITY (2002)
Share Paper
